Lurasidone Low-Dose - High-Dose Study Study
Clinical trial NCT01821378 · COMPLETED
Trial details
- NCT number
- NCT01821378
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.